87
Participants
Start Date
December 26, 2020
Primary Completion Date
March 27, 2024
Study Completion Date
April 17, 2024
HepTcell
Intramuscular injection
Placebo
Intramuscular injection
Univesritätsklinikum Hamburg-Eppendorf, Hamburg
Hospital Universitario La Paz, Madrid
Hospital Nuestra Señora De Valme, Seville
Consorcio Hospital General Universitario De Valencia, Valencia
Hospital Universitari I Politècnic La Fe, Valencia
Goethe University Hospital, Frankfurt am Main
Kansas City Research Institute, Kansas City
Central Sooner Research, Oklahoma City
Paragon Rx Clinical, Garden Grove
Stanford University Department of Medicine, Redwood City
San Jose Gastroenterology Institute, San Jose
University of Calgary Liver Unit - Heritage Medical Research Clinic, Calgary
University of Alberta Hospital, Edmonton
The Ottawa Hospital, Ottawa
Toronto Centre for Liver Disease (TCLD), Toronto General Hospital, UHN, Toronto
Toronto Liver Centre, Toronto
Hospital Clínic De Barcelona, Barcelona
Hospital Universitari Vall D'Hebron, Barcelona
St. Georges University of London, London
St. Mary's Hospital, London
Queens Medical Center, Nottingham
Lead Sponsor
Altimmune, Inc.
INDUSTRY